US Jury Awards $40 Million Against Johnson & Johnson in Talc-Related Ovarian Cancer Case
A Los Angeles Superior Court jury has awarded $40 million in compensatory damages against Johnson & Johnson in a talc-related ovarian cancer lawsuit involving two long-term users of the company’s baby powder products. The four-week trial was brought by plaintiffs Monica Kent and Deborah Schultz, who developed ovarian cancer after decades of using talc-based baby powder. The damages also include compensation for Deborah Schultz’s husband, Dr. Albert Schultz.
During the trial, jurors heard testimony from former U.S. Food and Drug Administration commissioner Dr. David Kessler, who cited internal Johnson & Johnson documents dating back to the 1970s. Kessler testified that the company was aware for decades of potential asbestos contamination risks associated with talc products. Medical experts presented epidemiological and pathological evidence suggesting a link between frequent genital talc use and an increased risk of ovarian cancer.
The verdict marks the first plaintiffs’ win in a talc–ovarian cancer case since 2021 and comes as the first of at least 10 similar trials expected through the first half of 2026. The case is separate from federal multidistrict litigation in New Jersey, where more than 70,000 talc-related claims remain pending after multiple unsuccessful bankruptcy efforts by Johnson & Johnson. The ruling intensifies legal, financial, and reputational pressure on legacy talc products and raises broader concerns across the beauty and personal care industry regarding talc sourcing, disclosure, and long-term safety.
Pic Courtesy: google/ images are subject to copyright
